Signal #159286 · SEC 8-K

$MRNA SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $MRNA filing catalyst

Why did $MRNA trigger an AI stock catalyst alert?

$MRNA triggered a Stock Catalyst AI alert on 2026-11-06 11:47:30 UTC for a SEC 8-K filing (AI Score: +7.5/10). Headline: Moderna Reports Q3 GAAP Profit of $0.38/Share, Raises 2026 Revenue Growth Guidance to 15%-25%. Key points: - Q3 revenue reached $1.31B (up from $1.02B YoY) with GAAP net income of $162M and diluted EPS of $0.38 vs. loss of $(0.51) prior year. - Raised FY2026 revenue growth outlook to 15%–25% (previously up to 10%) and lowered OpEx outlook by ~$0.2B. - Year-end cash projection increased to $8.1–$8.3B.

How did $MRNA stock react after the SEC filing?

After the SEC 8-K for $MRNA, observed market reaction: T0 price $241.46; peak move +8.42%. Past moves do not guarantee future results.

Where can I get real-time $MRNA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $MRNA via Telegram and the VIP Web Terminal from €10/month.

$MRNA

$MRNA – Moderna Reports Q3 GAAP Profit of $0.38/Share, Raises 2026 Revenue Growth Guidance to 15%-25%

Moderna, Inc.

2026-11-06 11:47:30 UTC · SEC 8-K · All $MRNA

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+7.5 / 10)

Q3 revenue reached $1.31B (up from $1.02B YoY) with GAAP net income of $162M and diluted EPS of $0.38 vs. loss of $(0.51) prior year.
Raised FY2026 revenue growth outlook to 15%–25% (previously up to 10%) and lowered OpEx outlook by ~$0.2B.
Year-end cash projection increased to $8.1–$8.3B.

Observed market reaction after signal

Peak +8.42%

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →